產(chǎn)品詳情
簡單介紹：
Anti-KCTD15抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-KCTD15抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-KCTD15
Cat. Number:
Anti-KCTD15抗體KL-16927R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
KCTD15 is a 283 amino acid protein that contains one BTB (POZ) domain and exists as two alternatively spliced isoforms. The gene that encodes KCTD15 consists of approximately 18,918 bases and maps to human chromosome 19q13.11. Consisting of around 63 million bases with more than 1,400 genes, chromosome Anti-KCTD15抗體19 makes up over 2% of the human genome. It is the genetic home for a number of immunoglobulin superfamily members including the killer cell and leukocyte Ig-like receptors, a number of ICAMs, the CEACAM and PSG families, and Fc?receptors. Key genes for eye color and hair color also map to chromosome 19. Peutz-Jeghers syndrome, spinocerebellar ataxia type 6, the stroke disorder CADASIL, hypercholesterolemia and insulin-dependent diabetes have been linked to chromosome 19. Translocations with chromosome 19 and chromosome 14 can be seen in some lymphoproliferative disorders and typically involve the proto-oncogene BCL3.
Also known as:
TB/POZ domain containing Anti-KCTD15抗體protein KCTD15; BTB/POZ domain-containing protein kctd15; KCD15_HUMAN; KCTD 15; kctd15; MGC25497; MGC2628; Potassium channel tetramerisation domain containing 15.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human KCTD15.
●
Predicted Molecular Weight: 32kDa.Anti-KCTD15抗體
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-KCTD15抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-KCTD15抗體
Optimal working dilutions must be determined by the end user.
